Shots:
- The US FDA has granted clearance to Sunrise Air, an at-home sleep apnea diagnostic platform designed to expand access to sleep care through a fully home-based testing solution, following a $29M funding round
- The lightweight, rechargeable device is built around the company’s mandibular jaw movement (MJM) tech, which captures chin movement signals & uses AI-supported algorithms to generate clinician-ready sleep reports
- The platform integrates thermistors for airflow monitoring, optical sensors for oxygen saturation & pulse rate tracking, plus an embedded microphone for snoring analysis to improve respiratory event detection, assess sleep fragmentation & respiratory effort, and distinguish obstructive from central sleep apnea, incl. in complex pts
Ref: Businesswire | Image: Sunrise Group | Press Release
Related News: Glooko Secures FDA Clearance for Cloud-Based EndoTool IV Insulin Dosing Platform
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
